Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Botulinum toxin and occupational therapy for Writer's cramp.
Park JE, Shamim EA, Panyakaew P, Mathew P, Toro C, Sackett J, Karp B, Lungu C, Alter K, Wu T, Ahmad OF, Villegas M, Auh S, Hallett M. Park JE, et al. Among authors: karp b. Toxicon. 2019 Nov;169:12-17. doi: 10.1016/j.toxicon.2019.07.010. Epub 2019 Jul 24. Toxicon. 2019. PMID: 31351085 Free PMC article. Clinical Trial.
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology.
Simpson DM, Hallett M, Ashman EJ, Comella CL, Green MW, Gronseth GS, Armstrong MJ, Gloss D, Potrebic S, Jankovic J, Karp BP, Naumann M, So YT, Yablon SA. Simpson DM, et al. Neurology. 2016 May 10;86(19):1818-26. doi: 10.1212/WNL.0000000000002560. Epub 2016 Apr 18. Neurology. 2016. PMID: 27164716 Free PMC article.
Positional Tremor and its Treatment.
Schaefer SM, Hallett M, Karp BP, DiCapua DB, Tinaz S. Schaefer SM, et al. Among authors: karp bp. Mov Disord Clin Pract. 2017 Sep-Oct;4(5):768-771. doi: 10.1002/mdc3.12498. Epub 2017 May 25. Mov Disord Clin Pract. 2017. PMID: 29057292 Free PMC article.
Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Simpson DM, Blitzer A, Brashear A, Comella C, Dubinsky R, Hallett M, Jankovic J, Karp B, Ludlow CL, Miyasaki JM, Naumann M, So Y; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Simpson DM, et al. Among authors: karp b. Neurology. 2008 May 6;70(19):1699-706. doi: 10.1212/01.wnl.0000311389.26145.95. Neurology. 2008. PMID: 18458230 Free PMC article.
Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone.
Wong ML, Kling MA, Munson PJ, Listwak S, Licinio J, Prolo P, Karp B, McCutcheon IE, Geracioti TD Jr, DeBellis MD, Rice KC, Goldstein DS, Veldhuis JD, Chrousos GP, Oldfield EH, McCann SM, Gold PW. Wong ML, et al. Among authors: karp b. Proc Natl Acad Sci U S A. 2000 Jan 4;97(1):325-30. doi: 10.1073/pnas.97.1.325. Proc Natl Acad Sci U S A. 2000. PMID: 10618417 Free PMC article. Clinical Trial.
Exercise and circadian rhythm-induced variations in plasma cortisol differentially regulate interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor-alpha (TNF alpha) production in humans: high sensitivity of TNF alpha and resistance of IL-6.
DeRijk R, Michelson D, Karp B, Petrides J, Galliven E, Deuster P, Paciotti G, Gold PW, Sternberg EM. DeRijk R, et al. Among authors: karp b. J Clin Endocrinol Metab. 1997 Jul;82(7):2182-91. doi: 10.1210/jcem.82.7.4041. J Clin Endocrinol Metab. 1997. PMID: 9215292
94 results